ReachMD
Be part of the knowledge.™Medtelligence
Medtelligence is dedicated to the creation of innovative, continuing medical education (CME) focusing on cardiovascular and cardiometabolic disease. Through the use of comprehensive, strategically aligned curricula, Medtelligence facilitates the sharing of research, knowledge, and clinical practice skills to engage medical practitioners to fulfill their commitment to lifelong professional development and ultimately improved patient care.
Episodes 1-9 of 9
CME/CE
Clinicians' Update on Omega-3s in ASCVD Risk Reduction
Clinicians' Update on Omega-3s in ASCVD Risk Reduction
CME/CE
Variable Effects of Omega-3 Fatty Acids for ASCVD Event Reduction: Why?
Variable Effects of Omega-3 Fatty Acids for ASCVD Event Reduction: Why?
CME/CE
Clinician’s Update on Omega-3s in ASCVD Risk Reduction
Clinician’s Update on Omega-3s in ASCVD Risk Reduction
CME/CE
Emerging Data on New Therapy Combinations for HFrEF: Raising Clinician Awareness
Emerging Data on New Therapy Combinations for HFrEF: Raising Clinician Awareness
CME/CE
Understanding the Differences Between STRENGTH and REDUCE-IT Omega-3 Fatty Acid Clinical Trials and EPA/DHA
Understanding the Differences Between STRENGTH and REDUCE-IT Omega-3 Fatty Acid Clinical Trials and EPA/DHA
- 4
CME/CE
Should EPA Be Another 'E' in the ABCs of CVD Risk Prevention? Straight Talk from the Experts
Should EPA Be Another 'E' in the ABCs of CVD Risk Prevention? Straight Talk from the Experts
CME/CE
New Therapies Offer Improved Outcomes in HFrEF Management
New Therapies Offer Improved Outcomes in HFrEF Management
CME/CE
New Opportunities to Manage Aortic Stenosis with TAVR
New Opportunities to Manage Aortic Stenosis with TAVR
CME/CE Broadcast Replay
The New Role of Omega-3 Fatty Acids in Reducing ASCVD Risk in Women: Expert Dialogue
The New Role of Omega-3 Fatty Acids in Reducing ASCVD Risk in Women: Expert Dialogue
